GB0917817D0 - Novel compounds and methods for their production - Google Patents

Novel compounds and methods for their production

Info

Publication number
GB0917817D0
GB0917817D0 GBGB0917817.9A GB0917817A GB0917817D0 GB 0917817 D0 GB0917817 D0 GB 0917817D0 GB 0917817 A GB0917817 A GB 0917817A GB 0917817 D0 GB0917817 D0 GB 0917817D0
Authority
GB
United Kingdom
Prior art keywords
production
methods
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0917817.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotica Technology Ltd
Original Assignee
Biotica Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotica Technology Ltd filed Critical Biotica Technology Ltd
Priority to GBGB0917817.9A priority Critical patent/GB0917817D0/en
Publication of GB0917817D0 publication Critical patent/GB0917817D0/en
Priority to PCT/GB2010/051714 priority patent/WO2011045594A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0917817.9A 2009-10-12 2009-10-12 Novel compounds and methods for their production Ceased GB0917817D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0917817.9A GB0917817D0 (en) 2009-10-12 2009-10-12 Novel compounds and methods for their production
PCT/GB2010/051714 WO2011045594A1 (en) 2009-10-12 2010-10-12 Novel macrocycles and methods for their production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0917817.9A GB0917817D0 (en) 2009-10-12 2009-10-12 Novel compounds and methods for their production

Publications (1)

Publication Number Publication Date
GB0917817D0 true GB0917817D0 (en) 2009-11-25

Family

ID=41402877

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0917817.9A Ceased GB0917817D0 (en) 2009-10-12 2009-10-12 Novel compounds and methods for their production

Country Status (2)

Country Link
GB (1) GB0917817D0 (en)
WO (1) WO2011045594A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108456213B (en) * 2017-02-22 2021-01-15 浙江九洲药业股份有限公司 Preparation method of 3-fluoro-4-hydroxycyclohexane carboxylate

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5563172A (en) 1991-09-05 1996-10-08 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
NZ295170A (en) 1994-10-26 1999-02-25 Novartis Ag Topical pharmaceutical compositions comprising a fk506 class compound, an unsaturated fatty alcohol, water and diether alcohol, alkanediol or ether diol as a solvent
CZ267796A3 (en) 1996-09-12 1998-04-15 Galena A.S. Medicamentous preparations, particularly for internal application in the form of inherently micro-emulsifying therapeutical systems
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
AU749475B2 (en) 1998-04-27 2002-06-27 Astellas Pharma Inc. Medicinal compositions
US6598153B1 (en) 1999-12-10 2003-07-22 International Business Machines Corporation Processor and method that accelerate evaluation of pairs of condition-setting and branch instructions
BR0312691A (en) 2002-07-16 2005-05-10 Biotica Tech Ltd Methods for converting a host strain into a recombinant strain, to generate a recombinant strain containing biosynthetic cluster, to produce an fbkp ligand analogue, to construct a collection of recombinant strand colonies, and to prepare a combinatorial fkbp ligand collection, collection of fbkp ligand analogs, recombinant strain, method for generating fbkp ligand analogs, compound, and use thereof
KR20060067922A (en) 2003-06-10 2006-06-20 아스텔라스세이야쿠 가부시키가이샤 Aerosol formulations in which an aerosol composition containing a macrolide compound is enclosed in an encapsulation container.
CA2552305A1 (en) 2003-12-30 2005-07-14 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
MX2007008662A (en) * 2005-01-20 2007-09-06 Array Biopharma Inc Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases.

Also Published As

Publication number Publication date
WO2011045594A1 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
SG10201403566SA (en) Composition and process for production thereof
HU0900759D0 (en) Novel process
GB0901254D0 (en) Process
GB0907879D0 (en) Process
GB0912255D0 (en) Process
GB0905998D0 (en) Process
GB0906191D0 (en) Process
GB0914500D0 (en) Process
GB0901817D0 (en) Process
GB0912254D0 (en) Process
GB0901816D0 (en) Process
GB0914572D0 (en) Process
GB0902286D0 (en) Process
GB0915106D0 (en) Process
GB0913318D0 (en) Process
GB0907942D0 (en) Process
GB0914589D0 (en) Novel compounds and methods for their production
GB0906031D0 (en) Process
GB0904540D0 (en) Novel compounds and methods for their production
GB0903956D0 (en) Process
GB0901822D0 (en) Process
GB0915627D0 (en) Process
GB0902287D0 (en) Process
GB0901824D0 (en) Process
GB0917817D0 (en) Novel compounds and methods for their production

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)